TY - T1的剥夺和肺动脉高血压患者的预后:失踪的影响剥夺一种罕见的疾病?摩根富林明-欧洲呼吸杂志》乔和J - 10.1183/13993003.02334 -2019欧元SP - 1902334 AU Eleni Sofianopoulou AU -科林教堂盟Gerry Coghlan AU -路加福音霍华德非盟-马丁约翰逊AU -大卫·g·基利AU -艾伦·洛瑞盟-詹姆斯Lordan AU -马丁·r·威尔金斯盟- Stephen J .麦芽汁非盟-尼古拉斯·w·莫雷尔盟马克。r . Toshner Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/03/26/13993003.02334 - 2019. -抽象N2 -在这个杂志,Pellino等人提出了生存分析评估不足如何影响肺动脉高血压患者的预后(PAH) [1]。剥夺他们的结论是,社会并不是一个重要的转诊障碍或预后因素特发性(我)多环芳烃或遗传(H)多环芳烃在苏格兰。这可能会出现奇怪的更广泛的环境文学描述结果分层社会剥夺。作者是彻底使用地址时诊断和审查时分配不足分数和比较两个,发现这两种方法之间没有显著差异。相比他们也剥夺分配到PAH病例根据苏格兰预期剥夺公民作为一个整体,发现社会剥夺了PAH患者超过预期。最后,他们使用相同的生存单变量分析调整年龄和性别来评估一些临床变量与预后有关。FootnotesThis手稿最近发表在《欧洲呼吸杂志》上。这里发表周全之前接受的形式排版,我们的生产团队。这些生产过程完成后,作者已经批准结果证明,本文将最新一期的ERJ在线。请打开或下载PDF查看这篇文章。Conflict of interest: Dr. Sofianopoulou has nothing to disclose.Conflict of interest: Dr. Church has nothing to disclose.Conflict of interest: Dr. Coghlan reports grants and personal fees from Johnson & Johnson, personal fees from Glaxo Smith Klein, personal fees from Bayer, personal fees from MSD, outside the submitted work.Conflict of interest: Dr. Howard has nothing to disclose.Conflict of interest: Dr. Johnson reports grants and personal fees from Actelion, grants and personal fees from MSD, outside the submitted work.Conflict of interest: Dr. Kiely has nothing to disclose.Conflict of interest: Dr. Lawrie reports grants from British Heart Foundataion, grants from Medical Research Council, grants, personal fees and other from Actelion Pharmaceuticals Ltd, grants and personal fees from GlaxoSmithKline, outside the submitted work.Conflict of interest: Dr. Lordan has nothing to disclose.Conflict of interest: Dr. Wilkins has nothing to disclose.Conflict of interest: Dr. Wort has nothing to disclose.Conflict of interest: Dr. Morrell has nothing to disclose.Conflict of interest: Dr. Toshner reports personal fees from GSK, grants and personal fees from J&J/Actelion, grants from Merck, grants from Bayer, outside the submitted work. ER -